Dosing & Uses
Prevention of Respiratory Syncytial Infection
Pending FDA approval for prevention of respiratory syncytial infection (RSV) in adults aged ≥60 years
Next:
Pharmacology
Mechanism of Action
Vaccine contains a recombinant subunit prefusion RSV F glycoprotein antigen (RSVPreF3) combined with AS01E adjuvant
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
